EPO Patents = 3

Forward Citations = 0

Loading Chart...

29 inventors (with patents filed for the assignee):

Chuanwen Fan (1 out of 4 patents)

Dong Lin (1 out of 2 patents)

Zhaowei Huang (1 out of 6 patents)

4. Qiang Fu (1 out of 1 patent)

5. Zhaofeng Ding (1 out of 1 patent)

6. Qingmin Wang (1 out of 1 patent)

7. Yue Yu (1 out of 3 patents)

8. Feifei Liu (1 out of 1 patent)

9. Guijiang Wang (1 out of 1 patent)

10. Daoyuan Li (1 out of 1 patent)

11. Jiulin Wang (1 out of 1 patent)

12. Peng Wan (1 out of 1 patent)

13. Bo Xie (1 out of 1 patent)

14. Xi Fang (1 out of 1 patent)

15. Huicheng Wang (1 out of 1 patent)

3 patents: Sort by Forward Citations

1. 12767650 - Crystal form of entrectinib and preparation method therefor (2026-10-20),

2. 12606578 - Crystal form of spirocyclic amine aryl phosphorus oxide compound and preparation method therefor (2026-04-21),

3. 12540345 - A COMPOSITION COMPRISING AFLIBERCEPT AND A VARIANT THEREOF, AND RELATED METHODS AND USES (2026-02-03),

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

3 Patents

#19 in JINAN

#8,360 in China

Jinan, China

Qilu Pharmaceutical Co., Ltd.

Forward Citations = 0

29 inventors:

Chuanwen Fan (1 out of 4 patents)

Dong Lin (1 out of 2 patents)

Zhaowei Huang (1 out of 6 patents)

4. Qiang Fu (1 out of 1 patent)

5. Zhaofeng Ding (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Qilu Pharmaceutical Co., Ltd.. Retrieved from https://idiyas.com/company/qilu-pharmaceutical

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

3 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]